在患有ST段升高心肌梗塞的患者中,血管学微血管抵抗的预后值
Gangzhen Qian1, Haoran Qin1, Dan Deng1
1Department of Cardiovascular Medicine, Center for Circadian Metabolism and Cardiovascular Disease, Southwest Hospital, Army Medical University, Chongqing, China.
透皮冠状动脉干预后测量的血管学微血管阻力 (AMR) 预测ST段升高心肌梗塞 (STEMI) 患者的不良结果. 基于AMR的诺基图增强了对死亡率或心力衰竭再入院的风险预测.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心血管研究研究心血管研究
背景情况:
- ST段升高心肌梗塞 (STEMI) 的管理依赖于反疗法.
- 微循环阻力指数 (IMR) 评估了微血管功能,但需要特定的工具.
- 血管学微血管阻力 (AMR) 提供了使用标准血管学的潜在替代方案.
研究的目的:
- 评估血管学微血管阻力 (AMR) 在初级皮肤冠状动脉干预 (PCI) 后STEMI患者的预后意义.
- 确定AMR是否可以预测不良心血管结果,特别是所有原因死亡率或心力衰竭再入院.
主要方法:
- 对232名接受初级PCI的STEMI患者进行了回顾性分析.
- 患者根据2.55mmHg*s/cm的值被分为高AMR和低AMR组.
- 综合终点:所有原因死亡率或心力衰竭再入院,通过最大选择的逻辑等级统计数据进行评估.
主要成果:
- 较高抗药性组对复合终点的风险显著增加 (HRadj: 3.33; p=0.03).
- AMR ≥ 2.55 mmHg*s/cm 独立预测了复合终点 (HR: 2.33; p=0.04).
- 纳米图包括AMR,年龄,性别,LVEF和PCI后QFR改善了STEMI患者的3年风险预测.
结论:
- 在PCI后的AMR测量对于STEMI患者来说是一个有价值的预后工具.
- 抗胰岛素耐药性预测了全因死亡和心力衰竭再入院的风险.
- 与AMR集成的诺基图增强了STEMI中不良结果的预测准确性.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
